MUSAS: Music for Sleep After Stroke

Sponsor
NHS Greater Glasgow and Clyde (Other)
Overall Status
Recruiting
CT.gov ID
NCT05867290
Collaborator
University of Glasgow (Other), University of Edinburgh (Other)
6
1
2
10.3
0.6

Study Details

Study Description

Brief Summary

Sleep difficulties are common following stroke yet effective evidence-based interventions for improving sleep in this population are lacking. A small number of studies have investigated the use of music listening as a way to improve sleep in adults with insomnia.

This study aims to examine whether a mindful music-listening intervention can reduce subjective and objective insomnia symptoms and improve mood and fatigue post-stroke.

Six adults with a clinical diagnosis of stroke presenting with an insomnia disorder will be recruited from stroke services within NHS Greater Glasgow and Clyde. A multiple baseline single case experimental design will be employed. Participants will be randomly allocated to a baseline phase of 7, 11 or 15 days, followed by a five-week mindful music-listening intervention incorporating sleep hygiene. Changes in subjective and objective sleep will be measured using questionnaires and actigraphy, respectively. Mood and fatigue will also be measured. The data will be analysed using visual inspection, Tau-U and multi-level modelling.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindful music-listening with sleep hygiene
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
6 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Single Case Experimental Design (SCED) methodology using multiple baseline across participants.Single Case Experimental Design (SCED) methodology using multiple baseline across participants.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Mindful Music-listening to as a Tool to Improve Sleep Post-stroke: A Single Case Experimental Design Study
Actual Study Start Date :
Feb 22, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Baseline Phase

Randomly allocated baseline phase (no intervention) of 7, 11 or 15 days.

Experimental: Intervention Phase

5 week mindful-music listening intervention including sleep hygiene

Behavioral: Mindful music-listening with sleep hygiene
5 week intervention consisting of sleep hygiene (week 1) and daily bedtime mindful music-listening for 30 minutes or until about to fall asleep, if sooner (weeks 2-5)

Outcome Measures

Primary Outcome Measures

  1. Sleep onset latency (SOL) [Measured daily, from baseline to follow-up (day 1 up to day day 71).]

    Time taken to fall asleep in minutes measured using actigraphy and a sleep diary completed by the participant. Higher scores indicate greater SOL.

Secondary Outcome Measures

  1. Total sleep time (TST) [Measured daily, from baseline to follow-up (day 1 up to day day 71).]

    Total time spent asleep in bed in minutes. Measured using actigraphy and a sleep diary completed by the participant. Higher scores indicated longer time spent asleep.

  2. Wake after sleep onset (WASO) [Measured daily, from baseline to follow-up (day 1 up to day day 71).]

    Total time spent awake after sleep onset in minutes. Measured using actigraphy and a sleep diary completed by the participant. Higher scores indicate longer time spent awake.

  3. Number of night time awakenings [Measured daily, from baseline to follow-up (day 1 up to day day 71).]

    Total number of awakenings during the night. Measured using actigraphy and a sleep diary completed by the participant. Min = 0 - no Max. Lower scores indicate fewer night time awakenings.

  4. Time in bed (TIB) [Measured daily, from baseline to follow-up (day 1 up to day day 71).]

    Total time spent in bed in minutes with higher scores indicating longer time spent in bed. Measured using a sleep diary completed by the participant.

  5. Sleep restoration [Measured daily, from baseline to follow-up (day 1 up to day day 71).]

    Participant rated level of sleep restoration on awakening. Measured using a 3-point scale: refreshed, somewhat refreshed, fatigued.

  6. Insomnia classification [Completed at baseline, end of intervention (week 1 to weeks 6-8 and at follow up (3 weeks post-intervention)]

    Sleep Condition Indicator (SCI) score. Min score= 0 - Max= 32 with lower scores indicating poorer sleep.

  7. Daytime sleepiness [Completed at baseline, at the end of intervention (week 1 to weeks 6-8) and at follow-up (3 weeks post-intervention)]

    Epworth Sleepiness Scale (ESS) score. Min score= 0 - Max= 24 with higher scores indicating greater levels of daytime sleepiness.

  8. Anxiety symptoms [Completed at baseline, end of intervention (week 1 to weeks 6-8 and at follow up (3 weeks post-intervention)]

    Generalized Anxiety Disorder Questionnaire (GAD-7) score. Min= 0 - Max= 21 with higher scores indicating more severe symptoms.

  9. Depressive symptoms [Completed at baseline, end of intervention (week 1 to weeks 6-8 and at follow up (3 weeks post-intervention)]

    Patient Health Questionnaire (PhQ-9) score. Min= 0 - Max= 27 with higher scores indicating more severe symptoms.

  10. Fatigue [Completed at baseline, end of intervention (week 1 to weeks 6-8 and at follow up (3 weeks post-intervention)]

    Fatigue Severity Scale (FSS) score. Min= 9 - Max= 63 with higher scores indicating greater fatigue severity.

  11. Adherence [Completed daily by the participant during the intervention music listening phase (weeks 3-5 to weeks 8-10)]

    Adherence to mindful music-listening as measured through music listening diary. Min= 0 - Max= 28 with higher scores indicating greater adherence.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • aged 18+ (no upper age limit);

  • clinically and/or radiologically confirmed diagnosis of stroke

  • score of ≤16 on the Sleep Condition Indicator (SCI; (Espie et al, 2018))

  • at least 3-months post-stroke

Exclusion Criteria:
  • Transient Ischemic Attack

  • subarachnoid hemorrhage

  • sleep medication commenced within the last 2 weeks (stable medication accepted)

  • significant receptive aphasia or major psychiatric/substance abuse problem preventing engagement in the intervention

  • deafness or severe hearing impairment preventing engagement in the intervention (use of hearing aids does not lead to exclusion where these support sufficient level of hearing for engagement)

  • unable to give informed consent.

  • participation in another intervention study with risk of contamination of study outcomes (determined on a case-by-case basis)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Greater Glasgow and Clyde Stroke Services Glasgow United Kingdom

Sponsors and Collaborators

  • NHS Greater Glasgow and Clyde
  • University of Glasgow
  • University of Edinburgh

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NHS Greater Glasgow and Clyde
ClinicalTrials.gov Identifier:
NCT05867290
Other Study ID Numbers:
  • GN22ST470
First Posted:
May 19, 2023
Last Update Posted:
May 19, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2023